8-K - Co-Diagnostics, Inc. | StockGist

Current Report Details

Event Type

Securities Modification+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

3.03

Material Modification to Rights of Security Holders As previously disclosed, on December 5, 2025, at a special meeting of the stockholders of Co-Diagnostics, In

Securities Modification

5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year The information set forth in Item 3.03 of this Current Report on Form 8-K is incorporat

Charter Amendment

7.01

. Regulation FD. Disclosure. On December 30, 2025, the Company issued a press release announcing the reverse stock split. The full text of the press release is

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation

Exhibits Only

Source Document

Exhibits (3)

3.1

EX-3.1

8-K

99.1

EX-99.1